Welcome to our dedicated page for ORMAT TECHNOLOGIES SEC filings (Ticker: ORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ORMAT TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ORMAT TECHNOLOGIES's regulatory disclosures and financial reporting.
SHARIR DAFNA reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Dafna Sharir received a grant of 899 Restricted Stock Units (RSUs) on June 2, 2026. Each RSU represents the right to receive one share of Ormat common stock upon vesting. This entire RSU grant will vest 100% on June 2, 2027, and the filing shows 899 derivative units held following the award.
Barniv Ravit reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Ravit Barniv received a grant of 899 Restricted Stock Units, each representing one share of ORA common stock upon vesting. The entire RSU award is scheduled to vest 100% on June 2, 2027, one year after the grant date.
Marom Michal reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Michal Marom received a grant of 899 Restricted Stock Units on June 2, 2026. Each RSU represents one share of ORA common stock upon vesting. This entire RSU grant is scheduled to vest 100% on June 2, 2027, and Marom now holds 899 RSUs directly.
Corfee Karin reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Karin Corfee received a grant of 899 Restricted Stock Units as equity compensation. Each RSU represents the right to receive one share of ORA common stock upon vesting. This entire RSU grant will vest 100% on June 2, 2027, and Corfee now holds 899 RSUs following the award.
Granot David reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director David Granot reported a new equity compensation award. He received a grant of 899 Restricted Stock Units, each representing the right to receive one share of Ormat common stock upon vesting. These RSUs vest 100% on June 2, 2027, which is the one-year anniversary of the grant date. Following this grant, Granot holds 899 RSUs directly, and the filing does not report any open-market stock purchases or sales, only this compensation-related award.
Ormat Technologies, Inc. reported results from its 2026 annual meeting of stockholders. Stockholders elected eight directors to serve until the 2027 annual meeting, with each nominee receiving more votes for than against; for example, Byron G. Wong received 49,896,718 votes for and 255,572 against.
Stockholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 47,012,094 votes for and 3,103,710 against, plus 55,778 abstentions and 1,206,958 broker non-votes. In addition, they ratified the appointment of Kesselman & Kesselman as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 51,202,458 votes for, 92,147 against, and 83,935 abstentions.
Ormat Technologies director Stanley Stern reported an open-market sale of 250 shares of common stock on May 27, 2026. The shares were sold at a weighted average price of $138.42 per share, in multiple trades between $138.38 and $138.49, leaving him with 5,800 shares owned directly.
ORA — Form 144 notice of proposed sale of restricted common stock. The filing lists 250 shares of Common Stock described as Restricted Stock to be sold by an issuer-related source, with an indicated value of $34,605.70. The filing also shows a prior sale of 577 shares on 05/15/2026 with an indicated value of $75,108.15. A total share count of 61,451,752 shares appears in the excerpt with an associated date of 05/27/2026.
Ormat Technologies director Michal Marom sold shares in an open-market trade. On May 19, 2026, Marom sold 3,080 shares of Ormat Technologies common stock in an open-market transaction at an average price of $130.975 per share. After the sale, Marom directly holds 1,766 shares of the company’s common stock.
Ormat Technologies director David Granot sold 3,519 shares of Common Stock in two open‑market transactions. He sold 1,753 shares at $132.70 per share on May 20, 2026, and 1,766 shares at $134.425 per share on May 21, 2026. These sales reduced his directly held Ormat shares to zero, and the filing shows no remaining derivative positions.